No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 3f1sA, 1.0000, 0.00, 1.000, 385, 385, CRYSTAL STRUCTURE OF PROTEIN Z COMPLEXED WITH PROTEIN Z-DEPENDENT INHIBITOR
2, 3h5cA, 0.9581, 1.35, 0.923, 384, 379, X-RAY STRUCTURE OF PROTEIN Z-PROTEIN Z INHIBITOR COMPLEX
3, 3kcgI, 0.9285, 2.15, 0.272, 419, 379, CRYSTAL STRUCTURE OF THE ANTITHROMBIN-FACTOR IXA- PENTASACCHARIDE COMPLEX
4, 4ajtA, 0.9249, 1.90, 0.751, 372, 370, THE CRYSTAL STRUCTURE OF MOUSE PROTEIN-Z DEPENDENT PROTEASE INHIBITOR(MZPI)
5, 2gd4C, 0.9166, 2.31, 0.271, 418, 377, CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX
6, 2gd4I, 0.9160, 2.32, 0.276, 417, 377, CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX
7, 1sr5A, 0.9160, 2.07, 0.270, 409, 374, ANTITHROMBIN-ANHYDROTHROMBIN-HEPARIN TERNARY COMPLEX STRUCTURE
8, 1jmoA, 0.9129, 1.95, 0.314, 425, 373, CRYSTAL STRUCTURE OF THE HEPARIN COFACTOR II-S195A THROMBIN COMPLEX
9, 1tb6I, 0.9121, 2.39, 0.268, 412, 377, 2.5A CRYSTAL STRUCTURE OF THE ANTITHROMBIN-THROMBIN-HEPARIN TERNARY COMPLEX
10, 1e03I, 0.9114, 2.29, 0.269, 418, 375, PLASMA ALPHA ANTITHROMBIN-III AND PENTASACCHARIDE
11, 1ophA, 0.9110, 1.75, 0.347, 375, 369, NON-COVALENT COMPLEX BETWEEN ALPHA-1-PI-PITTSBURGH AND S195A TRYPSIN
12, 1azxI, 0.9109, 2.41, 0.271, 417, 376, ANTITHROMBIN/PENTASACCHARIDE COMPLEX
13, 1hp7A, 0.9073, 1.80, 0.331, 376, 369, A 2.1 ANGSTROM STRUCTURE OF AN UNCLEAVED ALPHA-1-ANTITRYPSIN SHOWS VARIABILITY OF THE REACTIVE CENTER AND OTHER LOOPS
14, 5hgcA, 0.9047, 2.06, 0.314, 373, 369, A SERPIN STRUCTURE
15, 5ncsB, 0.9036, 1.93, 0.246, 374, 366, STRUCTURE OF THE NATIVE SERPIN-TYPE PROTEINASE INHIBITOR MIROPIN.
16, 5ncsA, 0.9031, 1.98, 0.246, 374, 366, STRUCTURE OF THE NATIVE SERPIN-TYPE PROTEINASE INHIBITOR MIROPIN.
17, 4if8A, 0.9014, 1.73, 0.304, 367, 365, STRUCTURE OF VASPIN
18, 1ovaD, 0.9014, 1.78, 0.247, 385, 365, CRYSTAL STRUCTURE OF UNCLEAVED OVALBUMIN AT 1.95 ANGSTROMS RESOLUTION
19, 4y40A, 0.9007, 1.76, 0.302, 366, 364, STRUCTURE OF VASPIN MUTANT D305C V383C
20, 2antI, 0.9007, 2.60, 0.272, 419, 378, THE 2.6 A STRUCTURE OF ANTITHROMBIN INDICATES A CONFORMATIONAL CHANGE AT THE HEPARIN BINDING SITE
21, 1ovaA, 0.8998, 1.83, 0.247, 383, 365, CRYSTAL STRUCTURE OF UNCLEAVED OVALBUMIN AT 1.95 ANGSTROMS RESOLUTION
22, 1nq9I, 0.8998, 2.34, 0.270, 406, 371, CRYSTAL STRUCTURE OF ANTITHROMBIN IN THE PENTASACCHARIDE-BOUND INTERMEDIATE STATE
23, 1dzhI, 0.8991, 2.64, 0.268, 417, 377, P14-FLUORESCEIN-N135Q-S380C-ANTITHROMBIN-III
24, 1e05I, 0.8986, 2.60, 0.266, 417, 376, PLASMA ALPHA ANTITHROMBIN-III
25, 4y3kA, 0.8982, 1.80, 0.305, 367, 364, STRUCTURE OF VASPIN MUTANT E379S
26, 1uhgD, 0.8965, 1.94, 0.252, 380, 365, CRYSTAL STRUCTURE OF S-OVALBUMIN AT 1.9 ANGSTROM RESOLUTION
27, 1e04I, 0.8962, 2.62, 0.269, 403, 375, PLASMA BETA ANTITHROMBIN-III
28, 4dy7C, 0.8957, 1.70, 0.279, 377, 362, CRYSTAL STRUCTURES OF PROTEASE NEXIN-1 IN COMPLEX WITH S195A THROMBIN
29, 3evjI, 0.8956, 2.40, 0.267, 404, 371, INTERMEDIATE STRUCTURE OF ANTITHROMBIN BOUND TO THE NATURAL PENTASACCHARIDE
30, 1uhgB, 0.8956, 1.86, 0.250, 380, 364, CRYSTAL STRUCTURE OF S-OVALBUMIN AT 1.9 ANGSTROM RESOLUTION
31, 1oyhI, 0.8950, 2.70, 0.268, 416, 377, CRYSTAL STRUCTURE OF P13 ALANINE VARIANT OF ANTITHROMBIN
32, 5io1A, 0.8941, 1.71, 0.334, 365, 362, CRYSTAL STRUCTURE OF RECOMBINANT HUMAN Z ALPHA-1-ANTITRYPSIN
33, 1qlpA, 0.8939, 1.89, 0.329, 372, 365, 2.0 ANGSTROM STRUCTURE OF INTACT ALPHA-1-ANTITRYPSIN: A CANONICAL TEMPLATE FOR ACTIVE SERPINS
34, 3druA, 0.8936, 1.61, 0.347, 363, 360, CRYSTAL STRUCTURE OF GLY117PHE ALPHA1-ANTITRYPSIN
35, 1oo8A, 0.8936, 1.79, 0.344, 370, 363, CRYSTAL STRUCTURE OF A1PI-PITTSBURGH IN THE NATIVE CONFORMATION
36, 2hijI, 0.8934, 2.64, 0.267, 411, 375, CRYSTAL STRUCTURE OF P14 ALANINE VARIANT OF ANTITHROMBIN
37, 1antI, 0.8928, 2.55, 0.267, 402, 374, BIOLOGICAL IMPLICATIONS OF A 3 ANGSTROMS STRUCTURE OF DIMERIC ANTITHROMBIN
38, 5io1B, 0.8924, 1.70, 0.335, 364, 361, CRYSTAL STRUCTURE OF RECOMBINANT HUMAN Z ALPHA-1-ANTITRYPSIN
39, 3ne4A, 0.8919, 1.82, 0.331, 370, 363, 1.8 ANGSTROM STRUCTURE OF INTACT NATIVE WILD-TYPE ALPHA-1-ANTITRYPSIN
40, 1ovaB, 0.8919, 1.76, 0.255, 371, 361, CRYSTAL STRUCTURE OF UNCLEAVED OVALBUMIN AT 1.95 ANGSTROMS RESOLUTION
41, 4dy7F, 0.8917, 1.94, 0.278, 378, 363, CRYSTAL STRUCTURES OF PROTEASE NEXIN-1 IN COMPLEX WITH S195A THROMBIN
42, 4if8B, 0.8915, 1.63, 0.302, 361, 358, STRUCTURE OF VASPIN
43, 4y3kB, 0.8913, 1.74, 0.301, 361, 359, STRUCTURE OF VASPIN MUTANT E379S
44, 1uhgA, 0.8913, 1.94, 0.253, 378, 363, CRYSTAL STRUCTURE OF S-OVALBUMIN AT 1.9 ANGSTROM RESOLUTION
45, 4x30A, 0.8912, 1.89, 0.320, 372, 363, CRYSTAL STRUCTURE OF HUMAN THYROXINE-BINDING GLOBULIN COMPLEXED WITH THYROINE AT 1.55 ANGSTROM RESOLUTION
46, 5nbuA, 0.8911, 1.91, 0.341, 370, 364, CRYSTAL STRUCTURE OF NATIVE ALPHA-1-ANTITRYPSIN WITH SEVEN STABILISING MUTATIONS
47, 4y40B, 0.8910, 1.78, 0.298, 361, 359, STRUCTURE OF VASPIN MUTANT D305C V383C
48, 3cwlA, 0.8910, 1.91, 0.330, 371, 364, CRYSTAL STRUCTURE OF ALPHA-1-ANTITRYPSIN CRYSTAL FORM B
49, 2b4xI, 0.8903, 2.63, 0.267, 413, 374, CRYSTAL STRUCTURE OF ANTITHROMBIN-III
50, 1athA, 0.8903, 2.42, 0.276, 389, 370, THE INTACT AND CLEAVED HUMAN ANTITHROMBIN III COMPLEX AS A MODEL FOR SERPIN-PROTEINASE INTERACTIONS
51, 3druB, 0.8899, 1.72, 0.344, 362, 360, CRYSTAL STRUCTURE OF GLY117PHE ALPHA1-ANTITRYPSIN
52, 2behI, 0.8899, 2.68, 0.269, 413, 375, CRYSTAL STRUCTURE OF ANTITHROMBIN VARIANT S137A/V317C/T401C WITH PLASMA LATENT ANTITHROMBIN
53, 1t1fC, 0.8894, 2.52, 0.270, 419, 370, CRYSTAL STRUCTURE OF NATIVE ANTITHROMBIN IN ITS MONOMERIC FORM
54, 1t1fB, 0.8894, 2.52, 0.270, 419, 370, CRYSTAL STRUCTURE OF NATIVE ANTITHROMBIN IN ITS MONOMERIC FORM
55, 1t1fA, 0.8894, 2.52, 0.270, 419, 370, CRYSTAL STRUCTURE OF NATIVE ANTITHROMBIN IN ITS MONOMERIC FORM
56, 4ga7A, 0.8893, 1.66, 0.292, 369, 356, CRYSTAL STRUCTURE OF HUMAN SERPINB1 MUTANT
57, 1dzgI, 0.8892, 2.71, 0.263, 422, 377, N135Q-S380C-ANTITHROMBIN-III
58, 1psiA, 0.8888, 1.94, 0.330, 371, 364, INTACT RECOMBINED ALPHA1-ANTITRYPSIN MUTANT PHE 51 TO LEU
59, 5nbvA, 0.8887, 1.88, 0.344, 369, 363, CRYSTAL STRUCTURE OF NATIVE ALPHA-1-ANTITRYPSIN WITH SEVEN STABILISING MUTATIONS
60, 1jmjB, 0.8883, 2.12, 0.314, 387, 366, CRYSTAL STRUCTURE OF NATIVE HEPARIN COFACTOR II
61, 3cwmA, 0.8880, 1.87, 0.331, 369, 362, CRYSTAL STRUCTURE OF ALPHA-1-ANTITRYPSIN COMPLEXED WITH CITRATE
62, 2zv6B, 0.8880, 2.10, 0.269, 371, 361, CRYSTAL STRUCTURE OF HUMAN SQUAMOUS CELL CARCINOMA ANTIGEN 1
63, 1jmjA, 0.8876, 2.12, 0.314, 397, 366, CRYSTAL STRUCTURE OF NATIVE HEPARIN COFACTOR II
64, 2qugA, 0.8870, 1.83, 0.330, 368, 361, CRYSTAL STRUCTURE OF ALPHA-1-ANTITRYPSIN CRYSTAL FORM A
65, 1sekA, 0.8863, 2.24, 0.247, 376, 365, THE STRUCTURE OF ACTIVE SERPIN K FROM MANDUCA SEXTA AND A MODEL FOR SERPIN-PROTEASE COMPLEX FORMATION
66, 3druC, 0.8859, 1.62, 0.350, 360, 357, CRYSTAL STRUCTURE OF GLY117PHE ALPHA1-ANTITRYPSIN
67, 4ga7B, 0.8846, 1.55, 0.288, 367, 354, CRYSTAL STRUCTURE OF HUMAN SERPINB1 MUTANT
68, 4dy0B, 0.8845, 1.81, 0.284, 370, 359, CRYSTAL STRUCTURE OF NATIVE PROTEASE NEXIN-1 WITH HEPARIN
69, 1ovaC, 0.8842, 1.63, 0.250, 373, 356, CRYSTAL STRUCTURE OF UNCLEAVED OVALBUMIN AT 1.95 ANGSTROMS RESOLUTION
70, 3drmA, 0.8830, 1.80, 0.331, 362, 359, 2.2 ANGSTROM CRYSTAL STRUCTURE OF THR114PHE ALPHA1- ANTITRYPSIN
71, 1yxaA, 0.8823, 1.86, 0.320, 372, 356, SERPINA3N A MURINE ORTHOLOGUE OF HUMAN ANTICHYMOTRYPSIN
72, 1jvqI, 0.8821, 2.86, 0.265, 410, 378, CRYSTAL STRUCTURE AT 2.6A OF THE TERNARY COMPLEX BETWEEN ANTITHROMBIN A P14-P8 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TETRAPEPTIDE
73, 1k9oI, 0.8813, 2.15, 0.267, 376, 363, CRYSTAL STRUCTURE OF MICHAELIS SERPIN-TRYPSIN COMPLEX
74, 1uhgC, 0.8812, 1.70, 0.256, 370, 356, CRYSTAL STRUCTURE OF S-OVALBUMIN AT 1.9 ANGSTROM RESOLUTION
75, 1r1lI, 0.8812, 2.86, 0.270, 416, 378, STRUCTURE OF DIMERIC ANTITHROMBIN COMPLEXED WITH A P14-P9 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TRIPEPTIDE (FORMYL-NORLEUCINE-LF)
76, 1lk6I, 0.8805, 2.87, 0.270, 410, 378, STRUCTURE OF DIMERIC ANTITHROMBIN COMPLEXED WITH A P14-P9 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TRIPEPTIDE
77, 5du3A, 0.8802, 2.29, 0.244, 378, 365, ACTIVE FORM OF HUMAN C1-INHIBITOR
78, 3f5nA, 0.8802, 2.07, 0.270, 364, 359, STRUCTURE OF NATIVE HUMAN NEUROSERPIN
79, 3fgqA, 0.8799, 2.02, 0.273, 374, 362, CRYSTAL STRUCTURE OF NATIVE HUMAN NEUROSERPIN
80, 3fgqB, 0.8798, 2.02, 0.273, 374, 362, CRYSTAL STRUCTURE OF NATIVE HUMAN NEUROSERPIN
81, 1yxaB, 0.8791, 1.79, 0.327, 368, 355, SERPINA3N A MURINE ORTHOLOGUE OF HUMAN ANTICHYMOTRYPSIN
82, 5du3B, 0.8790, 2.43, 0.243, 377, 366, ACTIVE FORM OF HUMAN C1-INHIBITOR
83, 2b5tI, 0.8789, 2.82, 0.261, 415, 372, 2.1 ANGSTROM STRUCTURE OF A NONPRODUCTIVE COMPLEX BETWEEN ANTITHROMBIN SYNTHETIC HEPARIN MIMETIC SR123781 AND TWO S195A THROMBIN MOLECULES
84, 1br8I, 0.8784, 2.80, 0.255, 404, 377, IMPLICATIONS FOR FUNCTION AND THERAPY OF A 2.9A STRUCTURE OF BINARY-COMPLEXED ANTITHROMBIN
85, 1xqgB, 0.8782, 2.14, 0.226, 378, 363, 3.10 A CRYSTAL STRUCTURE OF MASPIN SPACE GROUP P 4 21 2
86, 1imvA, 0.8780, 2.07, 0.260, 375, 361, 2.85 A CRYSTAL STRUCTURE OF PEDF
87, 3f5nD, 0.8778, 1.82, 0.275, 363, 356, STRUCTURE OF NATIVE HUMAN NEUROSERPIN
88, 2ol2A, 0.8775, 1.94, 0.332, 360, 355, HIGH RESOLUTION STRUCTURE OF NATIVE PCI IN SPACE GROUP P21
89, 3f5nB, 0.8767, 1.85, 0.275, 376, 356, STRUCTURE OF NATIVE HUMAN NEUROSERPIN
90, 2hi9A, 0.8764, 1.92, 0.334, 356, 353, CRYSTAL STRUCTURE OF HUMAN NATIVE PROTEIN C INHIBITOR
91, 2hi9B, 0.8763, 1.77, 0.332, 354, 352, CRYSTAL STRUCTURE OF HUMAN NATIVE PROTEIN C INHIBITOR
92, 1xqgA, 0.8763, 2.17, 0.226, 378, 363, 3.10 A CRYSTAL STRUCTURE OF MASPIN SPACE GROUP P 4 21 2
93, 2ceoA, 0.8762, 1.91, 0.329, 367, 356, THYROXINE-BINDING GLOBULIN COMPLEX WITH THYROXINE
94, 2ceoB, 0.8754, 1.95, 0.329, 367, 356, THYROXINE-BINDING GLOBULIN COMPLEX WITH THYROXINE
95, 3le2A, 0.8753, 2.44, 0.247, 393, 365, STRUCTURE OF ARABIDOPSIS ATSERPIN1. NATIVE STRESSED CONFORMATION
96, 5ce0B, 0.8749, 1.62, 0.390, 353, 351, CRYSTAL STRUCTURE OF CONSERPIN WITH Z-MUTATION
97, 1kctA, 0.8748, 2.49, 0.341, 375, 369, ALPHA1-ANTITRYPSIN
98, 5cdxA, 0.8741, 1.63, 0.402, 353, 351, CRYSTAL STRUCTURE OF CONSERPIN
99, 1xqjA, 0.8741, 2.20, 0.226, 378, 363, 3.10 A CRYSTAL STRUCTURE OF MASPIN SPACE GROUP I 4 2 2
100, 3ozqA, 0.8740, 2.04, 0.256, 364, 356, CRYSTAL STRUCTURE OF SERPIN48 WHICH IS A HIGHLY SPECIFIC SERPIN IN THE INSECT TENEBRIO MOLITOR
101, 3r4lA, 0.8722, 2.40, 0.275, 377, 364, HUMAN VERY LONG HALF LIFE PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1
102, 4dteA, 0.8715, 2.21, 0.256, 374, 363, CRYSTAL STRUCTURE OF ZEBRAFISH PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI- 1)
103, 1attB, 0.8700, 2.66, 0.270, 410, 370, CRYSTAL STRUCTURE OF CLEAVED BOVINE ANTITHROMBIN III AT 3.2 ANGSTROMS RESOLUTION
104, 1attA, 0.8699, 2.63, 0.266, 420, 368, CRYSTAL STRUCTURE OF CLEAVED BOVINE ANTITHROMBIN III AT 3.2 ANGSTROMS RESOLUTION
105, 3pb1I, 0.8692, 2.17, 0.274, 375, 361, CRYSTAL STRUCTURE OF A MICHAELIS COMPLEX BETWEEN PLASMINOGEN ACTIVATOR INHIBITOR-1 AND UROKINASE-TYPE PLASMINOGEN ACTIVATOR
106, 2h4rA, 0.8689, 1.97, 0.293, 371, 355, CRYSTAL STRUCTURE OF WILDTYPE MENT IN THE NATIVE CONFORMATION
107, 5ce0A, 0.8686, 1.65, 0.395, 352, 349, CRYSTAL STRUCTURE OF CONSERPIN WITH Z-MUTATION
108, 4dy0A, 0.8668, 1.77, 0.285, 362, 351, CRYSTAL STRUCTURE OF NATIVE PROTEASE NEXIN-1 WITH HEPARIN
109, 2r9yA, 0.8658, 1.98, 0.285, 365, 355, STRUCTURE OF ANTIPLASMIN
110, 1xu8B, 0.8657, 2.23, 0.229, 373, 358, THE 2.8 A STRUCTURE OF A TUMOUR SUPPRESSING SERPIN
111, 2peeB, 0.8646, 2.66, 0.225, 387, 364, CRYSTAL STRUCTURE OF A THERMOPHILIC SERPIN TENGPIN IN THE NATIVE STATE
112, 1db2A, 0.8642, 2.35, 0.277, 377, 361, CRYSTAL STRUCTURE OF NATIVE PLASMINOGEN ACTIVATOR INHIBITOR- 2 1
113, 5duqB, 0.8639, 2.12, 0.264, 365, 356, ACTIVE HUMAN C1-INHIBITOR IN COMPLEX WITH DEXTRAN SULFATE
114, 2peeA, 0.8628, 2.38, 0.225, 387, 360, CRYSTAL STRUCTURE OF A THERMOPHILIC SERPIN TENGPIN IN THE NATIVE STATE
115, 3zhaD, 0.8621, 2.47, 0.227, 368, 365, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
116, 4dteB, 0.8613, 2.07, 0.268, 364, 355, CRYSTAL STRUCTURE OF ZEBRAFISH PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI- 1)
117, 4eb1I, 0.8612, 3.15, 0.261, 411, 372, HYPERSTABLE IN-FRAME INSERTION VARIANT OF ANTITHROMBIN
118, 3b9fI, 0.8608, 2.10, 0.334, 356, 350, 1.6 A STRUCTURE OF THE PCI-THROMBIN-HEPARIN COMPLEX
119, 1by7A, 0.8608, 1.39, 0.289, 354, 343, HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-2. LOOP (66-98) DELETION MUTANT
120, 2zv6C, 0.8604, 1.42, 0.271, 350, 343, CRYSTAL STRUCTURE OF HUMAN SQUAMOUS CELL CARCINOMA ANTIGEN 1
121, 1xu8A, 0.8600, 1.91, 0.233, 365, 352, THE 2.8 A STRUCTURE OF A TUMOUR SUPPRESSING SERPIN
122, 5duqA, 0.8593, 1.96, 0.256, 362, 352, ACTIVE HUMAN C1-INHIBITOR IN COMPLEX WITH DEXTRAN SULFATE
123, 2zv6A, 0.8589, 1.47, 0.271, 350, 343, CRYSTAL STRUCTURE OF HUMAN SQUAMOUS CELL CARCINOMA ANTIGEN 1
124, 3vvjC, 0.8584, 2.19, 0.256, 384, 356, STRUCTURE OF OVALBUMIN FROM EMU (DROMAIUS NOVAEHOLLANDIAE)
125, 1atuA, 0.8579, 2.67, 0.339, 374, 369, UNCLEAVED ALPHA-1-ANTITRYPSIN
126, 3vvjB, 0.8561, 2.20, 0.253, 384, 356, STRUCTURE OF OVALBUMIN FROM EMU (DROMAIUS NOVAEHOLLANDIAE)
127, 3vvjA, 0.8559, 2.22, 0.253, 384, 356, STRUCTURE OF OVALBUMIN FROM EMU (DROMAIUS NOVAEHOLLANDIAE)
128, 1r1lL, 0.8557, 2.53, 0.274, 409, 361, STRUCTURE OF DIMERIC ANTITHROMBIN COMPLEXED WITH A P14-P9 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TRIPEPTIDE (FORMYL-NORLEUCINE-LF)
129, 3zhaA, 0.8549, 2.76, 0.228, 380, 368, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
130, 1e04L, 0.8549, 2.59, 0.266, 412, 361, PLASMA BETA ANTITHROMBIN-III
131, 3pzfA, 0.8548, 2.19, 0.244, 369, 353, 1.75A RESOLUTION STRUCTURE OF SERPIN-2 FROM ANOPHELES GAMBIAE
132, 2hi9C, 0.8548, 1.66, 0.332, 346, 343, CRYSTAL STRUCTURE OF HUMAN NATIVE PROTEIN C INHIBITOR
133, 1e05L, 0.8548, 2.59, 0.271, 417, 362, PLASMA ALPHA ANTITHROMBIN-III
134, 3zhaC, 0.8546, 2.54, 0.227, 376, 365, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
135, 2ol2B, 0.8544, 1.47, 0.337, 343, 341, HIGH RESOLUTION STRUCTURE OF NATIVE PCI IN SPACE GROUP P21
136, 1dvmA, 0.8544, 2.36, 0.275, 375, 356, ACTIVE FORM OF HUMAN PAI-1
137, 6cj7A, 0.8542, 1.92, 0.263, 357, 350, CRYSTAL STRUCTURE OF MANDUCA SEXTA SERINE PROTEASE INHIBITOR (SERPIN)- 12 
138, 1br8L, 0.8542, 2.55, 0.275, 398, 360, IMPLICATIONS FOR FUNCTION AND THERAPY OF A 2.9A STRUCTURE OF BINARY-COMPLEXED ANTITHROMBIN
139, 1dzgL, 0.8540, 2.59, 0.266, 409, 361, N135Q-S380C-ANTITHROMBIN-III
140, 1dvmD, 0.8536, 2.37, 0.275, 372, 356, ACTIVE FORM OF HUMAN PAI-1
141, 3zhaB, 0.8535, 2.45, 0.230, 364, 361, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
142, 1dvmC, 0.8523, 2.18, 0.277, 364, 354, ACTIVE FORM OF HUMAN PAI-1
143, 2antL, 0.8521, 2.58, 0.275, 398, 360, THE 2.6 A STRUCTURE OF ANTITHROMBIN INDICATES A CONFORMATIONAL CHANGE AT THE HEPARIN BINDING SITE
144, 1dvmB, 0.8520, 2.17, 0.280, 365, 353, ACTIVE FORM OF HUMAN PAI-1
145, 2b4xL, 0.8518, 2.61, 0.271, 410, 361, CRYSTAL STRUCTURE OF ANTITHROMBIN-III
146, 4g8oC, 0.8517, 2.17, 0.275, 367, 353, CRYSTAL STRUCTURE OF A NOVEL SMALL MOLECULE INACTIVATOR BOUND TO PLASMINOGEN ACTIVATOR INHIBITOR-1
147, 4g8oD, 0.8516, 2.30, 0.271, 367, 354, CRYSTAL STRUCTURE OF A NOVEL SMALL MOLECULE INACTIVATOR BOUND TO PLASMINOGEN ACTIVATOR INHIBITOR-1
148, 4roaA, 0.8515, 2.24, 0.244, 364, 352, 1.90A RESOLUTION STRUCTURE OF SRPN2 (S358W) FROM ANOPHELES GAMBIAE
149, 2hijL, 0.8515, 2.61, 0.267, 409, 360, CRYSTAL STRUCTURE OF P14 ALANINE VARIANT OF ANTITHROMBIN
150, 4g8rB, 0.8511, 2.18, 0.275, 368, 353, CRYSTAL STRUCTURE OF A NOVEL SMALL MOLECULE INACTIVATOR BOUND TO PLASMINOGEN ACTIVATOR INHIBITOR-1
151, 2behL, 0.8506, 2.57, 0.279, 403, 359, CRYSTAL STRUCTURE OF ANTITHROMBIN VARIANT S137A/V317C/T401C WITH PLASMA LATENT ANTITHROMBIN
152, 1dzhL, 0.8502, 2.62, 0.269, 407, 360, P14-FLUORESCEIN-N135Q-S380C-ANTITHROMBIN-III
153, 1oyhL, 0.8501, 2.66, 0.263, 410, 361, CRYSTAL STRUCTURE OF P13 ALANINE VARIANT OF ANTITHROMBIN
154, 1wz9B, 0.8500, 2.07, 0.232, 355, 349, THE 2.1 A STRUCTURE OF A TUMOUR SUPPRESSING SERPIN
155, 3q03B, 0.8499, 2.27, 0.277, 364, 354, CRYSTAL STRUCTURE OF PLASMINOGEN ACTIVATOR INHIBITOR-1 IN A METASTABLE ACTIVE CONFORMATION.
156, 4au4G, 0.8496, 2.60, 0.237, 368, 363, CRYSTAL STRUCTURE OF HSP47
157, 4au4C, 0.8495, 2.63, 0.227, 370, 365, CRYSTAL STRUCTURE OF HSP47
158, 1lk6L, 0.8495, 2.58, 0.267, 406, 359, STRUCTURE OF DIMERIC ANTITHROMBIN COMPLEXED WITH A P14-P9 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TRIPEPTIDE
159, 1db2B, 0.8494, 2.21, 0.281, 362, 352, CRYSTAL STRUCTURE OF NATIVE PLASMINOGEN ACTIVATOR INHIBITOR- 2 1
160, 5brrI, 0.8491, 2.50, 0.268, 372, 358, MICHAELIS COMPLEX OF TPA-S195A:PAI-1
161, 4au4F, 0.8490, 2.59, 0.234, 368, 363, CRYSTAL STRUCTURE OF HSP47
162, 3zhaL, 0.8490, 2.63, 0.231, 369, 364, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
163, 3q03A, 0.8489, 2.08, 0.280, 360, 350, CRYSTAL STRUCTURE OF PLASMINOGEN ACTIVATOR INHIBITOR-1 IN A METASTABLE ACTIVE CONFORMATION.
164, 3q02B, 0.8489, 2.21, 0.276, 362, 352, CRYSTAL STRUCTURE OF PLASMINOGEN ACTIVATOR INHIBITOR-1 IN A METASTABLE ACTIVE CONFORMATION.
165, 1jvqL, 0.8489, 2.59, 0.270, 406, 359, CRYSTAL STRUCTURE AT 2.6A OF THE TERNARY COMPLEX BETWEEN ANTITHROMBIN A P14-P8 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TETRAPEPTIDE
166, 2dutD, 0.8483, 2.19, 0.293, 366, 351, CRYSTAL STRUCTURE OF A M-LOOP DELETION VARIANT OF MENT IN THE NATIVE CONFORMATION
167, 2dutC, 0.8483, 2.19, 0.293, 366, 351, CRYSTAL STRUCTURE OF A M-LOOP DELETION VARIANT OF MENT IN THE NATIVE CONFORMATION
168, 2dutB, 0.8483, 2.19, 0.293, 366, 351, CRYSTAL STRUCTURE OF A M-LOOP DELETION VARIANT OF MENT IN THE NATIVE CONFORMATION
169, 2dutA, 0.8483, 2.19, 0.293, 366, 351, CRYSTAL STRUCTURE OF A M-LOOP DELETION VARIANT OF MENT IN THE NATIVE CONFORMATION
170, 1jtiA, 0.8482, 2.09, 0.254, 381, 351, LOOP-INSERTED STRUCTURE OF P1-P1  CLEAVED OVALBUMIN MUTANT R339T
171, 4ic0C, 0.8481, 2.19, 0.273, 366, 352, CRYSTAL STRUCTURE OF PAI-1 IN COMPLEX WITH GALLATE
172, 4rsqK, 0.8479, 2.16, 0.244, 356, 348, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
173, 2vdxA, 0.8479, 2.11, 0.299, 366, 351, CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED CORTICOSTEROID BINDING GLOBULIN
174, 1jtiB, 0.8479, 2.09, 0.254, 381, 351, LOOP-INSERTED STRUCTURE OF P1-P1  CLEAVED OVALBUMIN MUTANT R339T
175, 4ic0A, 0.8478, 2.20, 0.273, 366, 352, CRYSTAL STRUCTURE OF PAI-1 IN COMPLEX WITH GALLATE
176, 3zhaP, 0.8475, 2.75, 0.227, 373, 366, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
177, 1b3kC, 0.8471, 2.40, 0.277, 373, 354, PLASMINOGEN ACTIVATOR INHIBITOR-1
178, 1b3kA, 0.8470, 2.40, 0.277, 373, 354, PLASMINOGEN ACTIVATOR INHIBITOR-1
179, 4robB, 0.8468, 2.15, 0.244, 356, 348, 2.8A RESOLUTION STRUCTURE OF SRPN2 (K198C) FROM ANOPHELES GAMBIAE
180, 3zhaQ, 0.8467, 2.55, 0.229, 365, 362, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
181, 3ut3C, 0.8467, 2.41, 0.277, 368, 354, A NOVEL PAI-I INHIBITOR AND ITS STRUCTURAL MECHANISM
182, 4ro9A, 0.8465, 2.09, 0.254, 353, 347, 2.0A RESOLUTION STRUCTURE OF SRPN2 (S358E) FROM ANOPHELES GAMBIAE
183, 3ut3D, 0.8462, 2.12, 0.280, 360, 350, A NOVEL PAI-I INHIBITOR AND ITS STRUCTURAL MECHANISM
184, 3ut3B, 0.8459, 2.12, 0.280, 360, 350, A NOVEL PAI-I INHIBITOR AND ITS STRUCTURAL MECHANISM
185, 4rsqL, 0.8457, 2.21, 0.244, 356, 348, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
186, 4ic0D, 0.8457, 2.08, 0.278, 359, 349, CRYSTAL STRUCTURE OF PAI-1 IN COMPLEX WITH GALLATE
187, 4eb1L, 0.8456, 2.49, 0.272, 392, 356, HYPERSTABLE IN-FRAME INSERTION VARIANT OF ANTITHROMBIN
188, 4au4D, 0.8456, 2.59, 0.235, 366, 361, CRYSTAL STRUCTURE OF HSP47
189, 4rsqE, 0.8455, 2.21, 0.244, 356, 348, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
190, 4rsqG, 0.8454, 2.28, 0.244, 357, 349, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
191, 3ut3A, 0.8453, 2.27, 0.278, 367, 352, A NOVEL PAI-I INHIBITOR AND ITS STRUCTURAL MECHANISM
192, 3zhaK, 0.8446, 2.89, 0.228, 374, 368, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
193, 4rsqH, 0.8445, 2.35, 0.244, 357, 349, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
194, 4g8oB, 0.8445, 2.10, 0.278, 359, 349, CRYSTAL STRUCTURE OF A NOVEL SMALL MOLECULE INACTIVATOR BOUND TO PLASMINOGEN ACTIVATOR INHIBITOR-1
195, 4c41A, 0.8445, 2.23, 0.290, 367, 352, CORTICOSTEROID-BINDING GLOBULIN WITH ENGINEERED DISULPHIDE BRIDGE BETWEEN RESIDUES 100 AND 236
196, 4rsqB, 0.8442, 2.22, 0.245, 355, 347, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
197, 3f5nC, 0.8442, 2.21, 0.256, 358, 347, STRUCTURE OF NATIVE HUMAN NEUROSERPIN
198, 3q02A, 0.8441, 2.03, 0.279, 358, 348, CRYSTAL STRUCTURE OF PLASMINOGEN ACTIVATOR INHIBITOR-1 IN A METASTABLE ACTIVE CONFORMATION.
199, 4rsqF, 0.8440, 2.11, 0.249, 353, 346, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
200, 4g8oA, 0.8437, 2.11, 0.275, 359, 349, CRYSTAL STRUCTURE OF A NOVEL SMALL MOLECULE INACTIVATOR BOUND TO PLASMINOGEN ACTIVATOR INHIBITOR-1
201, 1azxL, 0.8435, 2.84, 0.271, 414, 361, ANTITHROMBIN/PENTASACCHARIDE COMPLEX
202, 1e03L, 0.8434, 2.84, 0.274, 423, 361, PLASMA ALPHA ANTITHROMBIN-III AND PENTASACCHARIDE
203, 4ic0B, 0.8433, 2.08, 0.279, 358, 348, CRYSTAL STRUCTURE OF PAI-1 IN COMPLEX WITH GALLATE
204, 4rsqA, 0.8431, 2.24, 0.245, 356, 347, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
205, 3ndaA, 0.8428, 2.53, 0.305, 374, 357, CRYSTAL STRUCTURE OF SERPIN FROM TICK IXODES RICINUS
206, 1antL, 0.8428, 2.60, 0.272, 392, 357, BIOLOGICAL IMPLICATIONS OF A 3 ANGSTROMS STRUCTURE OF DIMERIC ANTITHROMBIN
207, 4au4B, 0.8427, 2.66, 0.234, 368, 363, CRYSTAL STRUCTURE OF HSP47
208, 4c49A, 0.8426, 2.16, 0.291, 367, 351, REACTIVE LOOP CLEAVED HUMAN CBG IN COMPLEX WITH CORTISOL
209, 5c98B, 0.8422, 2.53, 0.165, 364, 357, 1.45A RESOLUTION STRUCTURE OF SRPN18 FROM ANOPHELES GAMBIAE
210, 4robA, 0.8420, 2.21, 0.245, 356, 347, 2.8A RESOLUTION STRUCTURE OF SRPN2 (K198C) FROM ANOPHELES GAMBIAE
211, 4au4A, 0.8420, 2.62, 0.233, 366, 361, CRYSTAL STRUCTURE OF HSP47
212, 4pywA, 0.8418, 2.48, 0.338, 362, 358, 1.92 ANGSTROM CRYSTAL STRUCTURE OF A1AT:TTAI TERNARY COMPLEX
213, 4au4E, 0.8408, 2.67, 0.229, 367, 362, CRYSTAL STRUCTURE OF HSP47
214, 1nq9L, 0.8408, 2.76, 0.267, 413, 359, CRYSTAL STRUCTURE OF ANTITHROMBIN IN THE PENTASACCHARIDE-BOUND INTERMEDIATE STATE
215, 5ei0A, 0.8407, 2.39, 0.305, 372, 357, STRUCTURE OF RCL-CLEAVED VASPIN (SERPINA12)
216, 1oc0A, 0.8407, 2.29, 0.283, 364, 350, PLASMINOGEN ACTIVATOR INHIBITOR-1 COMPLEX WITH SOMATOMEDIN B DOMAIN OF VITRONECTIN
217, 1b3kB, 0.8407, 2.13, 0.279, 358, 348, PLASMINOGEN ACTIVATOR INHIBITOR-1
218, 3evjL, 0.8406, 2.72, 0.265, 417, 359, INTERMEDIATE STRUCTURE OF ANTITHROMBIN BOUND TO THE NATURAL PENTASACCHARIDE
219, 2vdyB, 0.8406, 2.03, 0.301, 361, 346, CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED CORTICOSTEROID BINDING GLOBULIN COMPLEXED WITH CORTISOL
220, 1b3kD, 0.8406, 2.13, 0.279, 358, 348, PLASMINOGEN ACTIVATOR INHIBITOR-1
221, 4rsqJ, 0.8402, 2.21, 0.246, 355, 346, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
222, 4p0oA, 0.8402, 2.42, 0.277, 371, 354, CLEAVED SERPIN 42DA
223, 4au2A, 0.8402, 2.66, 0.232, 367, 362, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
224, 2vdxB, 0.8397, 2.05, 0.301, 360, 346, CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED CORTICOSTEROID BINDING GLOBULIN
225, 4ro9B, 0.8396, 1.94, 0.251, 348, 342, 2.0A RESOLUTION STRUCTURE OF SRPN2 (S358E) FROM ANOPHELES GAMBIAE
226, 4rsqI, 0.8395, 2.32, 0.245, 356, 347, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
227, 4rsqD, 0.8395, 2.34, 0.244, 355, 348, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
228, 4c49C, 0.8392, 2.08, 0.296, 363, 348, REACTIVE LOOP CLEAVED HUMAN CBG IN COMPLEX WITH CORTISOL
229, 4c49B, 0.8392, 2.16, 0.293, 362, 348, REACTIVE LOOP CLEAVED HUMAN CBG IN COMPLEX WITH CORTISOL
230, 4robC, 0.8382, 2.14, 0.244, 351, 344, 2.8A RESOLUTION STRUCTURE OF SRPN2 (K198C) FROM ANOPHELES GAMBIAE
231, 4g8rA, 0.8382, 2.13, 0.280, 357, 347, CRYSTAL STRUCTURE OF A NOVEL SMALL MOLECULE INACTIVATOR BOUND TO PLASMINOGEN ACTIVATOR INHIBITOR-1
232, 4rsqC, 0.8369, 2.17, 0.247, 354, 344, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
233, 5ei0E, 0.8368, 2.38, 0.307, 371, 355, STRUCTURE OF RCL-CLEAVED VASPIN (SERPINA12)
234, 3f5nE, 0.8358, 1.57, 0.268, 340, 336, STRUCTURE OF NATIVE HUMAN NEUROSERPIN
235, 2vdyA, 0.8356, 2.11, 0.298, 361, 346, CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED CORTICOSTEROID BINDING GLOBULIN COMPLEXED WITH CORTISOL
236, 4au2D, 0.8352, 2.46, 0.229, 359, 354, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
237, 1wz9A, 0.8345, 2.11, 0.232, 357, 345, THE 2.1 A STRUCTURE OF A TUMOUR SUPPRESSING SERPIN
238, 5c98A, 0.8341, 2.38, 0.169, 359, 350, 1.45A RESOLUTION STRUCTURE OF SRPN18 FROM ANOPHELES GAMBIAE
239, 4zk0A, 0.8332, 2.18, 0.270, 367, 348, PSORIASIS PATHOGENESIS - PSO P27 CONSTITUTE A COMPACT STRUCTURE FORMING LARGE AGGREGATES. HIGH PH STRUCTURE
240, 3ndaB, 0.8329, 2.43, 0.302, 372, 354, CRYSTAL STRUCTURE OF SERPIN FROM TICK IXODES RICINUS
241, 4au3D, 0.8325, 2.53, 0.220, 359, 355, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
242, 1a7cA, 0.8324, 2.48, 0.282, 364, 354, HUMAN PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN COMPLEX WITH A PENTAPEPTIDE
243, 4zk3A, 0.8300, 2.19, 0.268, 366, 347, PSORIASIS PATHOGENESIS - PSO P27 CONSTITUTE A COMPACT STRUCTURE FORMING LARGE AGGREGATES. LOW PH STRUCTURE
244, 4au2B, 0.8299, 2.38, 0.234, 354, 351, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
245, 2wy0C, 0.8294, 3.02, 0.210, 424, 362, CRYSTAL STRUCTURE OF MOUSE ANGIOTENSINOGEN IN THE OXIDISED FORM WITH SPACE GROUP P6122
246, 2arqA, 0.8278, 2.38, 0.280, 360, 350, HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-2.[LOOP (66-98) DELETION MUTANT] COMPLEXED WITH PEPTIDE N-ACETYL-TEAAAGDGGVMTGR-OH
247, 2wxyC, 0.8270, 3.01, 0.211, 419, 361, CRYSTAL STRUCTURE OF MOUSE ANGIOTENSINOGEN IN THE REDUCED FORM
248, 2arrA, 0.8267, 2.42, 0.280, 358, 350, HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-2.[LOOP (66-98) DELETION MUTANT] COMPLEXED WITH PEPTIDE N-ACETYL-TEAAAGMGGVMTGR-OH
249, 3cvmA, 0.8253, 2.56, 0.278, 377, 352, HIGH RESOLUTION STRUCTURE OF A STABLE PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN ITS PROTEASE CLEAVED FORM
250, 3cvmB, 0.8236, 2.58, 0.278, 377, 352, HIGH RESOLUTION STRUCTURE OF A STABLE PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN ITS PROTEASE CLEAVED FORM
251, 5m3yA, 0.8218, 3.11, 0.208, 418, 361, CRYSTAL STRUCTURE OF HUMAN GLYCOSYLATED ANGIOTENSINOGEN
252, 4r9iA, 0.8215, 3.03, 0.137, 378, 358, CRYSTAL STRUCTURE OF CYSTEINE PROTEINASE INHIBITOR SERPIN18 FROM BOMBYX MORI
253, 2wxzA, 0.8214, 3.47, 0.218, 422, 371, CRYSTAL STRUCTURE OF RAT ANGIOTENSINOGEN IN C2 SPACE GROUP
254, 1jrrA, 0.8208, 2.44, 0.284, 357, 348, HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-2.[LOOP (66-98) DELETIONMUTANT] COMPLEXED WITH PEPTIDE MIMICKING THE REACTIVE CENTER LOOP
255, 4au3C, 0.8206, 2.75, 0.216, 357, 356, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
256, 4c49D, 0.8203, 2.12, 0.296, 356, 341, REACTIVE LOOP CLEAVED HUMAN CBG IN COMPLEX WITH CORTISOL
257, 2x0bH, 0.8203, 3.04, 0.211, 423, 361, CRYSTAL STRUCTURE OF HUMAN ANGIOTENSINOGEN COMPLEXED WITH RENIN
258, 2x0bF, 0.8203, 3.04, 0.211, 423, 361, CRYSTAL STRUCTURE OF HUMAN ANGIOTENSINOGEN COMPLEXED WITH RENIN
259, 2x0bD, 0.8203, 3.04, 0.211, 423, 361, CRYSTAL STRUCTURE OF HUMAN ANGIOTENSINOGEN COMPLEXED WITH RENIN
260, 2x0bB, 0.8203, 3.04, 0.211, 423, 361, CRYSTAL STRUCTURE OF HUMAN ANGIOTENSINOGEN COMPLEXED WITH RENIN
261, 3eoxA, 0.8181, 2.64, 0.283, 370, 350, HIGH QUALITY STRUCTURE OF CLEAVED PAI-1-STAB
262, 4p0fA, 0.8178, 2.40, 0.275, 369, 345, CLEAVED SERPIN 42DA (C 2 2 21)
263, 2wxwA, 0.8173, 3.25, 0.209, 438, 363, CRYSTAL STRUCTURE OF HUMAN ANGIOTENSINOGEN
264, 4ro9C, 0.8163, 1.85, 0.251, 336, 331, 2.0A RESOLUTION STRUCTURE OF SRPN2 (S358E) FROM ANOPHELES GAMBIAE
265, 4au3A, 0.8162, 2.69, 0.221, 354, 353, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
266, 4afxA, 0.8162, 2.28, 0.988, 347, 338, CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED ZPI IN I2 SPACE GROUP
267, 4au3B, 0.8158, 2.56, 0.226, 351, 349, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
268, 2wxxC, 0.8158, 3.16, 0.211, 422, 361, CRYSTAL STRUCTURE OF MOUSE ANGIOTENSINOGEN IN THE OXIDISED FORM
269, 1sngA, 0.8154, 2.25, 0.256, 349, 336, STRUCTURE OF A THERMOPHILIC SERPIN IN THE NATIVE STATE
270, 2wxxD, 0.8132, 3.14, 0.211, 411, 360, CRYSTAL STRUCTURE OF MOUSE ANGIOTENSINOGEN IN THE OXIDISED FORM
271, 3dlwA, 0.8127, 2.59, 0.309, 360, 343, ANTICHYMOTRYPSIN
272, 2wxxB, 0.8122, 3.21, 0.213, 428, 362, CRYSTAL STRUCTURE OF MOUSE ANGIOTENSINOGEN IN THE OXIDISED FORM
273, 2wxxA, 0.8122, 3.17, 0.208, 412, 361, CRYSTAL STRUCTURE OF MOUSE ANGIOTENSINOGEN IN THE OXIDISED FORM
274, 1qmnA, 0.8084, 2.85, 0.316, 365, 345, ALPHA1-ANTICHYMOTRYPSIN SERPIN IN THE DELTA CONFORMATION (PARTIAL LOOP INSERTION)
275, 4ajuA, 0.8064, 2.42, 0.964, 349, 336, CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED ZPI IN P41 SPACE GROUP
276, 2wy1B, 0.8050, 3.35, 0.224, 417, 362, CRYSTAL STRUCTURE OF RAT ANGIOTENSINOGEN IN P321 SPACE GROUP
277, 2wy1A, 0.8050, 3.35, 0.224, 418, 362, CRYSTAL STRUCTURE OF RAT ANGIOTENSINOGEN IN P321 SPACE GROUP
278, 3stoA, 0.8049, 2.79, 0.212, 361, 344, SERPIN FROM THE TREMATODE SCHISTOSOMA HAEMATOBIUM
279, 2wxzC, 0.8048, 3.43, 0.221, 413, 362, CRYSTAL STRUCTURE OF RAT ANGIOTENSINOGEN IN C2 SPACE GROUP
280, 2v95A, 0.8039, 2.40, 0.253, 342, 340, STRUCTURE OF CORTICOSTEROID-BINDING GLOBULIN IN COMPLEX WITH CORTISOL
281, 5cdzA, 0.8038, 2.45, 0.401, 361, 339, CRYSTAL STRUCTURE OF CONSERPIN IN THE LATENT STATE
282, 2pefA, 0.8009, 2.69, 0.233, 366, 344, CRYSTAL STRUCTURE OF A THERMOPHILIC SERPIN TENGPIN IN THE LATENT STATE
283, 4aqhA, 0.7997, 2.78, 0.277, 382, 346, PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN COMPLEX WITH THE INHIBITOR AZ3976
284, 1athB, 0.7983, 2.18, 0.282, 362, 333, THE INTACT AND CLEAVED HUMAN ANTITHROMBIN III COMPLEX AS A MODEL FOR SERPIN-PROTEINASE INTERACTIONS
285, 4au2C, 0.7973, 2.28, 0.228, 338, 334, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
286, 4aqhB, 0.7959, 2.83, 0.280, 383, 346, PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN COMPLEX WITH THE INHIBITOR AZ3976
287, 4aqhC, 0.7952, 2.85, 0.277, 382, 346, PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN COMPLEX WITH THE INHIBITOR AZ3976
288, 1iz2A, 0.7918, 2.93, 0.342, 371, 348, INTERACTIONS CAUSING THE KINETIC TRAP IN SERPIN PROTEIN FOLDING
289, 1c5gA, 0.7908, 3.06, 0.284, 379, 348, PLASMINOGEN ACTIVATOR INHIBITOR-1
290, 3lw2A, 0.7887, 2.48, 0.281, 365, 334, MOUSE PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1)
291, 2oayA, 0.7869, 2.74, 0.251, 368, 338, CRYSTAL STRUCTURE OF LATENT HUMAN C1-INHIBITOR
292, 5m3xB, 0.7847, 3.04, 0.213, 387, 347, CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN I-DELETED ANGIOTENSINOGEN
293, 1dvnA, 0.7832, 3.07, 0.283, 379, 346, LATENT FORM OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1)
294, 4kdsA, 0.7826, 2.81, 0.275, 370, 338, CRYSTAL STRUCTURE OF LATENT RAINBOW TROUT PLASMINOGEN ACTIVATOR INHIBITOR 1 (PAI-1)
295, 5m3xA, 0.7817, 3.02, 0.217, 383, 345, CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN I-DELETED ANGIOTENSINOGEN
296, 2vh4A, 0.7813, 3.01, 0.236, 380, 343, STRUCTURE OF A LOOP C-SHEET SERPIN POLYMER
297, 1lj5A, 0.7809, 3.22, 0.282, 379, 347, 1.8A RESOLUTION STRUCTURE OF LATENT PLASMINOGEN ACTIVATOR INHIBITOR-1(PAI-1)
298, 2xn5A, 0.7793, 2.30, 0.307, 341, 326, CRYSTAL STRUCTURE OF THYROXINE-BINDING GLOBULIN COMPLEXED WITH FUROSEMIDE
299, 2h4qA, 0.7780, 2.55, 0.272, 352, 331, CRYSTAL STRUCTURE OF A M-LOOP DELETION VARIANT OF MENT IN THE CLEAVED CONFORMATION
300, 2rivA, 0.7772, 2.38, 0.305, 339, 325, CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED HUMAN THYROXINE BINDING GLOBULIN
301, 5om7A, 0.7765, 2.24, 0.322, 338, 323, CRYSTAL STRUCTURE OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-II: A DRUG- BINDING SERPIN FOR DOXORUBICIN 
302, 2xn7A, 0.7762, 2.28, 0.306, 339, 324, CRYSTAL STRUCTURE OF THYROXINE-BINDING GLOBULIN COMPLEXED WITH THYROXINE-FLUORESEIN (T405-CF)
303, 4yiaA, 0.7750, 2.29, 0.303, 337, 323, STRUCTURAL MECHANISM OF HORMONE RELEASE IN THYROXINE BINDING GLOBULIN
304, 5om2A, 0.7748, 2.27, 0.322, 338, 323, CRYSTAL STRUCTURE OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-I1: A DRUG- BINDING SERPIN FOR DOXYCYCLINE 
305, 2riwA, 0.7737, 2.24, 0.307, 337, 322, THE REACTIVE LOOP CLEAVED HUMAN THYROXINE BINDING GLOBULIN COMPLEXED WITH THYROXINE
306, 2xn6A, 0.7726, 2.26, 0.307, 337, 322, CRYSTAL STRUCTURE OF THYROXINE-BINDING GLOBULIN COMPLEXED WITH THYROXINE-FLUORESEIN
307, 2xn3A, 0.7724, 2.26, 0.307, 337, 322, CRYSTAL STRUCTURE OF THYROXINE-BINDING GLOBULIN COMPLEXED WITH MEFENAMIC ACID
308, 2vh4B, 0.7721, 2.83, 0.239, 374, 335, STRUCTURE OF A LOOP C-SHEET SERPIN POLYMER
309, 5om3A, 0.7667, 2.33, 0.324, 335, 321, CRYSTAL STRUCTURE OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-I5: A MMP14- CLEAVABLE DRUG-BINDING SERPIN FOR DOXYCYCLINE 
310, 1as4A, 0.7656, 2.36, 0.327, 336, 321, CLEAVED ANTICHYMOTRYPSIN A349R
311, 2h4pA, 0.7647, 2.72, 0.274, 350, 328, CRYSTAL STRUCTURE OF WILDTYPE MENT IN THE CLEAVED CONFORMATION
312, 5om6A, 0.7638, 2.49, 0.318, 339, 324, CRYSTAL STRUCTURE OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-I-ALLO2: A MMP9-CLEAVABLE DRUG-BINDING SERPIN FOR DOXYCYCLINE 
313, 5ncwA, 0.7634, 2.49, 0.233, 334, 322, STRUCTURE OF THE TRYPSIN INDUCED SERPIN-TYPE PROTEINASE INHIBITOR MIROPIN (V367K/K368A MUTANT).
314, 4bb2A, 0.7623, 2.38, 0.278, 332, 320, CRYSTAL STRUCTURE OF CLEAVED CORTICOSTEROID-BINDING GLOBULIN IN COMPLEX WITH PROGESTERONE
315, 2achA, 0.7620, 2.45, 0.329, 337, 322, CRYSTAL STRUCTURE OF CLEAVED HUMAN ALPHA1-ANTICHYMOTRYPSIN AT 2.7 ANGSTROMS RESOLUTION AND ITS COMPARISON WITH OTHER SERPINS
316, 3caaA, 0.7617, 2.34, 0.326, 334, 319, CLEAVED ANTICHYMOTRYPSIN A347R
317, 5om5A, 0.7609, 2.58, 0.318, 338, 324, CRYSTAL STRUCTURE OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-I-ALLO1: AN ALLOSTERICALLY TRIGGERED DRUG-BINDING SERPIN FOR DOXYCYCLINE 
318, 6ftpA, 0.7608, 2.39, 0.325, 335, 320, CRYSTAL FORM 1 OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-II-ALLO: AN ALLOSTERICALLY MODULATED DRUG-BINDING SERPIN FOR DOXORUBICIN 
319, 3nddA, 0.7596, 2.60, 0.322, 335, 323, CLEAVED ANTITRYPSIN WITH P10 PRO AND P9-P6 ASP
320, 8apiA, 0.7591, 2.66, 0.322, 340, 326, THE S VARIANT OF HUMAN ALPHA1-ANTITRYPSIN STRUCTURE AND IMPLICATIONS FOR FUNCTION AND METABOLISM
321, 5inwA, 0.7581, 2.46, 0.275, 335, 320, STRUCTURE OF REACTION LOOP CLEAVED LAMPREY ANGIOTENSINOGEN
322, 3ndfA, 0.7577, 2.51, 0.326, 336, 322, CLEAVED ANTITRYPSIN WITH P8-P6 ASP
323, 5om8A, 0.7572, 2.57, 0.320, 336, 322, CRYSTAL FORM 2 OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-II-ALLO: AN ALLOSTERICALLY MODULATED DRUG-BINDING SERPIN FOR DOXORUBICIN 
324, 9apiA, 0.7570, 2.65, 0.323, 339, 325, THE S VARIANT OF HUMAN ALPHA1-ANTITRYPSIN STRUCTURE AND IMPLICATIONS FOR FUNCTION AND METABOLISM
325, 1d5sA, 0.7566, 2.74, 0.322, 334, 326, CRYSTAL STRUCTURE OF CLEAVED ANTITRYPSIN POLYMER
326, 7apiA, 0.7563, 2.66, 0.323, 339, 325, THE S VARIANT OF HUMAN ALPHA1-ANTITRYPSIN STRUCTURE AND IMPLICATIONS FOR FUNCTION AND METABOLISM
327, 1hleA, 0.7560, 2.46, 0.281, 344, 320, CRYSTAL STRUCTURE OF CLEAVED EQUINE LEUCOCYTE ELASTASE INHIBITOR DETERMINED AT 1.95 ANGSTROMS RESOLUTION
328, 2d26A, 0.7549, 2.70, 0.331, 336, 323, ACTIVE SITE DISTORTION IS SUFFICIENT FOR PROTEINASE INHIBIT SECOND CRYSTAL STRUCTURE OF COVALENT SERPIN-PROTEINASE COMPLEX
329, 2znhA, 0.7539, 2.66, 0.266, 408, 320, CRYSTAL STRUCTURE OF A DOMAIN-SWAPPED SERPIN DIMER
330, 5inwB, 0.7528, 2.41, 0.278, 331, 317, STRUCTURE OF REACTION LOOP CLEAVED LAMPREY ANGIOTENSINOGEN
331, 4caaA, 0.7517, 2.47, 0.327, 333, 318, CLEAVED ANTICHYMOTRYPSIN T345R
332, 1ezxA, 0.7487, 2.74, 0.326, 335, 322, CRYSTAL STRUCTURE OF A SERPIN:PROTEASE COMPLEX
333, 3t1pA, 0.7486, 2.79, 0.322, 371, 323, CRYSTAL STRUCTURE OF AN ALPHA-1-ANTITRYPSIN TRIMER
334, 2znhB, 0.7480, 2.52, 0.268, 412, 317, CRYSTAL STRUCTURE OF A DOMAIN-SWAPPED SERPIN DIMER
335, 5ncuA, 0.7477, 2.45, 0.238, 329, 315, STRUCTURE OF THE SUBTILISIN INDUCED SERPIN-TYPE PROTEINASE INHIBITOR MIROPIN.
336, 9paiA, 0.7451, 2.96, 0.261, 346, 326, CLEAVED SUBSTRATE VARIANT OF PLASMINOGEN ACTIVATOR INHIBITOR-1
337, 1lq8G, 0.7439, 2.60, 0.329, 330, 316, CRYSTAL STRUCTURE OF CLEAVED PROTEIN C INHIBITOR
338, 1lq8A, 0.7425, 2.59, 0.329, 329, 316, CRYSTAL STRUCTURE OF CLEAVED PROTEIN C INHIBITOR
339, 1qmbA, 0.7421, 2.74, 0.325, 326, 320, CLEAVED ALPHA-1-ANTITRYPSIN POLYMER
340, 5om6C, 0.7420, 2.75, 0.312, 335, 321, CRYSTAL STRUCTURE OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-I-ALLO2: A MMP9-CLEAVABLE DRUG-BINDING SERPIN FOR DOXYCYCLINE 
341, 3dy0A, 0.7412, 2.55, 0.330, 327, 315, CRYSTAL STRUCTURE OF CLEAVED PCI BOUND TO HEPARIN
342, 5nctA, 0.7401, 2.47, 0.240, 325, 312, STRUCTURE OF THE TRYPSIN INDUCED SERPIN-TYPE PROTEINASE INHIBITOR MIROPIN.
343, 1lq8C, 0.7391, 2.59, 0.330, 328, 315, CRYSTAL STRUCTURE OF CLEAVED PROTEIN C INHIBITOR
344, 1lq8E, 0.7362, 2.64, 0.327, 329, 315, CRYSTAL STRUCTURE OF CLEAVED PROTEIN C INHIBITOR
345, 3f02B, 0.7319, 2.47, 0.262, 327, 309, CLEAVED HUMAN NEUROSERPIN
346, 3f02A, 0.7170, 2.47, 0.263, 322, 304, CLEAVED HUMAN NEUROSERPIN
347, 1mtpA, 0.7128, 2.79, 0.239, 320, 306, THE X-RAY CRYSTAL STRUCTURE OF A SERPIN FROM A THERMOPHILIC PROKARYOTE
348, 1c8oA, 0.6796, 2.53, 0.250, 300, 288, 2.9 A STRUCTURE OF CLEAVED VIRAL SERPIN CRMA
349, 1f0cA, 0.6512, 2.66, 0.246, 297, 280, STRUCTURE OF THE VIRAL SERPIN CRMA
350, 1m93B, 0.5361, 2.84, 0.252, 245, 234, 1.65 A STRUCTURE OF CLEAVED VIRAL SERPIN CRMA
351, 1jjoD, 0.5307, 2.50, 0.262, 244, 225, CRYSTAL STRUCTURE OF MOUSE NEUROSERPIN (CLEAVED FORM)
352, 1jjoC, 0.5307, 2.50, 0.262, 244, 225, CRYSTAL STRUCTURE OF MOUSE NEUROSERPIN (CLEAVED FORM)
